Additional areas of investigation Researchers are also studying semaglutide in obstructive sleep apnea (where weight loss significantly improves symptoms), heart failure with preserved ejection fraction (HFpEF), peripheral artery disease, polycystic ovary syndrome, and even addiction disorders
Interest in using weight-loss medications Among participants who had not used a GLP-1, GLP-1/GIP, or other medication for weight loss in the past year (96.0% [95.596.6%] of the sample), 6.5% [5.77.3%] said they would be likely to consider using a weight-loss medication in the next year (2.5% [2.13.0%] very likely and 4.0% [3.44.6%] fairly likely
Introduzione Tirzepatide e warfarin sono due farmaci che possono trovarsi a convivere nella stessa terapia: il primo per il trattamento dellobesit, il secondo come anticoagulante in pazienti con fibrillazione atriale, protesi valvolari meccaniche o trombosi venose pregresse
Testimonials Kind Words from Our Patients Discover the stories of lives transformed and experiences shared by our valued patients